Randomized Clinical Trial to Assess the Impact of the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01 on HIV-1 Persistence in Individuals on Effective ART
Author(s) -
Sharon A. Riddler,
Lu Zheng,
Christine M. Durand,
Justin Ritz,
Richard A. Koup,
Julie E. Ledgerwood,
Robert T. Bailer,
Susan L. Koletar,
Joseph J. Eron,
Michael C. Keefer,
Bernard Macatangay,
Joshua C. Cyktor,
John W. Mellors,
Mark Hite,
Jan Clark,
D. Currin,
Mandy Tipton,
Renee Weinman,
Sara Onesi,
Christine Hurley,
Catherine A. Bunce,
Sheryl Storey,
Shelia B. Dunaway,
Nina Lambert,
Baiba Berzins,
Joan Gottesman,
Michael Leonard,
Graham Ray,
Pat Kittelson,
C. Benson,
Leticia Muttera,
Teri Flynn,
Amy Sbrolla,
Ilene Wiggins,
Jamilla Howard,
Roberto C. Arduino,
Aristoteles E Villamil,
Lisa Kessels,
Teresa Spitz,
Danielle Campbell,
Mwenda Kudumu,
Thucuma Sise,
Apsara Nair,
Jenifer Baer,
Kim Epperson,
Alan S. Perelson,
Cheryl Jennings,
Randall Tressler,
Ed Acosta,
Joseph P. Casazza,
Alex Benns
Publication year - 2018
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofy242
Subject(s) - viremia , medicine , placebo , immunology , ionomycin , monoclonal antibody , neutralizing antibody , virology , antibody , persistence (discontinuity) , randomized controlled trial , stimulation , pathology , alternative medicine , geotechnical engineering , engineering
NCT02411539.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom